Regulatory Approvals

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

Oct 12, 2026

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to…

Regulatory Approvals

Plane Support wins approval for 3-D-printed helicopter parts

Oct 12, 2026

Plane Support wins approval for 3-D-printed helicopter parts AviTrader Aviation News

Regulatory Approvals

US FDA approves tucatinib with trastuzumab & pertuzumab for HER2+ breast cancer

Oct 12, 2026

US FDA approves tucatinib with trastuzumab & pertuzumab for HER2+ breast cancer Oncology Central

Regulatory Approvals

Asahi Kasei wins FDA approval for Hovilpri

Oct 12, 2026

Asahi Kasei wins FDA approval for Hovilpri The Pharma Letter

Regulatory Approvals

FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats

Oct 11, 2026

The U.S. Food and Drug Administration today issued an Emergency Use Authorization (EUA) for Capstar (nitenpyram) tablets and revised the…

Regulatory Approvals

Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised Adults

Plane Support wins approval for 3-D-printed helicopter parts

US FDA approves tucatinib with trastuzumab & pertuzumab for HER2+ breast cancer

Asahi Kasei wins FDA approval for Hovilpri

FDA Issues Emergency Use Authorization for Drugs to Prevent and Treat New World Screwworm in Dogs and Cats

Financial News For All

Qualcomm to cut jobs worldwide in performance-focused layoffs, internal memo shows

EXCLUSIVE: Qualcomm to cut jobs worldwide in performance-focused layoffs, internal memo shows

California state workers are about to strike. What that means for the DMV, EDD, parks and more

FDA approves first generic estradiol/levonorgestrel weekly patch